Umeå University's logo

umu.sePublications
System disruptions
We are currently experiencing disruptions on the search portals due to high traffic. We are working to resolve the issue, you may temporarily encounter an error message.
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • apa-6th-edition.csl
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Serine protease inhibitors restrict host susceptibility to SARS-CoV-2 infections
Umeå University, Faculty of Medicine, Department of Clinical Microbiology. Umeå University, Faculty of Medicine, Molecular Infection Medicine Sweden (MIMS).ORCID iD: 0000-0001-8512-0535
Umeå University, Faculty of Medicine, Molecular Infection Medicine Sweden (MIMS). Umeå University, Faculty of Medicine, Department of Molecular Biology (Faculty of Medicine). National Clinical Research School in Chronic Inflammatory Diseases (NCRSCID), Karolinska Institutet, Solna, Sweden.
Umeå University, Faculty of Medicine, Department of Clinical Microbiology. Umeå University, Faculty of Medicine, Wallenberg Centre for Molecular Medicine at Umeå University (WCMM). Institute for Experimental Virology, TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between The Medical School Hannover, The Helmholtz Centre for Infection Research, Hannover, Germany; Department of Biochemistry & Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover, Hannover, Germany.ORCID iD: 0000-0002-3634-066x
Umeå University, Faculty of Medicine, Molecular Infection Medicine Sweden (MIMS). Umeå University, Faculty of Medicine, Department of Molecular Biology (Faculty of Medicine).
Show others and affiliations
2022 (English)In: mBio, ISSN 2161-2129, E-ISSN 2150-7511, Vol. 13, no 3, article id e00892-22Article in journal (Refereed) Published
Abstract [en]

The coronavirus disease 2019, COVID-19, is a complex disease with a wide range of symptoms from asymptomatic infections to severe acute respiratory syndrome with lethal outcome. Individual factors such as age, sex, and comorbidities increase the risk for severe infections, but other aspects, such as genetic variations, are also likely to affect the susceptibility to SARS-CoV-2 infection and disease severity. Here, we used a human 3D lung cell model based on primary cells derived from multiple donors to identity host factors that regulate SARS-CoV-2 infection. With a transcriptomics-based approach, we found that less susceptible donors show a higher expression level of serine protease inhibitors SERPINA1, SERPINE1, and SERPINE2, identifying variation in cellular serpin levels as restricting host factors for SARS-CoV-2 infection. We pinpoint their antiviral mechanism of action to inhibition of the cellular serine protease, TMPRSS2, thereby preventing cleavage of the viral spike protein and TMPRSS2-mediated entry into the target cells. By means of single-cell RNA sequencing, we further locate the expression of the individual serpins to basal, ciliated, club, and goblet cells. Our results add to the importance of genetic variations as determinants for SARS-CoV-2 susceptibility and suggest that genetic deficiencies of cellular serpins might represent risk factors for severe COVID-19. Our study further highlights TMPRSS2 as a promising target for antiviral intervention and opens the door for the usage of locally administered serpins as a treatment against COVID-19.

Place, publisher, year, edition, pages
American Society for Microbiology, 2022. Vol. 13, no 3, article id e00892-22
Keywords [en]
A1AT, alpha-1-antitrypsin, antithrombin III, ATIII, COVID-19, PAI1, plasminogen activator inhibitor 1, SARS-CoV-2, serpin, TMPRSS2
National Category
Infectious Medicine
Identifiers
URN: urn:nbn:se:umu:diva-203186DOI: 10.1128/mbio.00892-22ISI: 000797888900001PubMedID: 35532162Scopus ID: 2-s2.0-85133144334OAI: oai:DiVA.org:umu-203186DiVA, id: diva2:1727739
Funder
Science for Life Laboratory, SciLifeLabSwedish National Infrastructure for Computing (SNIC), SNIC 2020/6-251Swedish Heart Lung Foundation, 2020038Knut and Alice Wallenberg Foundation, 2020.0182Knut and Alice Wallenberg Foundation, C19R:028Swedish Society for Medical Research (SSMF)The Kempe Foundations, JCK-1827Swedish Research Council, 2016-06598Available from: 2023-01-17 Created: 2023-01-17 Last updated: 2024-11-01Bibliographically approved
In thesis
1. A systems biology single cell approach for querying the differentiation of immune system and antiviral response
Open this publication in new window or tab >>A systems biology single cell approach for querying the differentiation of immune system and antiviral response
2024 (English)Doctoral thesis, comprehensive summary (Other academic)
Alternative title[sv]
En systembiologisk studie av differentiering av immunförsvaret och antiviral respons på nivån av individuella celler
Abstract [en]

This thesis leverages the power of single-cell RNA and ATAC sequencing to enhance our understanding of the innate and adaptive immune systems in higher mammals. The primary focus is on the transcriptional networks that guide the activation and differentiation of human primary CD4+ T cells into Th1, Th2, Th17, and iTreg subsets, using a GMP-based protocol and ex vivo/in vitro approaches. Additionally, computational models for gene regulatory network (GRN) inference and analysis were employed to elucidate gene regulation using a data-driven, multi-omics approach. This research also encompasses viral response-related studies to provide a comprehensive view of the immune response, specifically targeting the central nervous system (CNS) upon TBEV infection and lung tissues during SARS-CoV-2 infection.

In Paper 1, a multi-omics linear and non-linear approach is developed to predict gene popularity using a large number of high-throughput sequencing datasets. We show that additional omics layers are beneficial to construct GRNs capable of accurately predicting gene popularity. In Paper 2, a comprehensive atlas of human primary CD4+ T cell activation and differentiation is created using in vitro cell differentiation and single-cell RNA and ATAC sequencing. Novel gene regulatory dynamics of JUNB are identified, and a new probabilistic approach based on Markov chains for GRN analysis and interpretation is introduced. In Paper 3, the connection between type I interferon response in the mouse brain and TBEV infection is explored using single nuclei RNA sequencing. In Paper 4, the role of intrinsic resistance factors in human COVID-19 susceptibility is investigated using both single-cell and bulk RNA sequencing, and identifies SERPINS as critical regulators of the process.

The findings of this thesis contribute significantly to the understanding of transcriptional networks governing human CD4+ T cell differentiation and activation. This work aims to improve therapy and demonstrate the efficacy of NGS and computational tools in deciphering the transcriptional networks involved in various viral infections.

Place, publisher, year, edition, pages
Umeå: Umeå University, 2024. p. 84
Series
Umeå University medical dissertations, ISSN 0346-6612 ; 2332
Keywords
scRNA-seq, scATAC-seq, snRNA-seq, innate immune system, adaptive immune system, CD4+ T cells, Th1, Th2, Th17, iTreg, gene regulatory networks, community detection, multi-omics, tick-borne encephalitis virus, SARS-CoV-2, NGS, SERPIN, type I interferon, mouse, human
National Category
Cell and Molecular Biology Bioinformatics (Computational Biology) Immunology Genetics and Genomics Bioinformatics and Computational Biology
Research subject
Molecular Biology; Genetics; biology; Immunology; Computer Science
Identifiers
urn:nbn:se:umu:diva-231112 (URN)9789180705462 (ISBN)9789180705479 (ISBN)
Public defence
2024-11-25, Major Groove 6L, Norrlands universitetssjukhus, Umeå, 09:00 (English)
Opponent
Supervisors
Available from: 2024-11-04 Created: 2024-11-01 Last updated: 2025-02-05Bibliographically approved

Open Access in DiVA

fulltext(2345 kB)303 downloads
File information
File name FULLTEXT01.pdfFile size 2345 kBChecksum SHA-512
b9fcc9e0503d3a602a66e7a3453ed7a3428722019c654297a726f79609751674ab06878f0965955c3f05c28f7f7b5a81a4d0460d1095771bc149d7bd3d2e5141
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Rosendal, EbbaMihai, Ionut SebastianBecker, MiriamDas, DebojyotiFrängsmyr, LarsPersson, B. DavidRankin, GregoryGröning, RemigiusTrygg, JohanForsell, MattiasBlomberg, AndersHenriksson, JohanÖverby, Anna K.Lenman, Annasara

Search in DiVA

By author/editor
Rosendal, EbbaMihai, Ionut SebastianBecker, MiriamDas, DebojyotiFrängsmyr, LarsPersson, B. DavidRankin, GregoryGröning, RemigiusTrygg, JohanForsell, MattiasBlomberg, AndersHenriksson, JohanÖverby, Anna K.Lenman, Annasara
By organisation
Department of Clinical MicrobiologyMolecular Infection Medicine Sweden (MIMS)Department of Molecular Biology (Faculty of Medicine)Wallenberg Centre for Molecular Medicine at Umeå University (WCMM)Section of MedicineDepartment of Chemistry
In the same journal
mBio
Infectious Medicine

Search outside of DiVA

GoogleGoogle Scholar
Total: 303 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 575 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • apa-6th-edition.csl
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf